|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Virginia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing VirginiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Teva Pharmaceuticals USA
Teva
| | | Phone: | (434) 534-8600 | Fax: | (434) 543-8630 | Year Established: | 1972 | Ticker: | TEVA | Exchange: | NYSE | Main Contact: | Kåre Schultz, President & CEO | | Other Contacts: | Sven Dethlefs, Executive VP, Global Marketing & Portfolio Hafrun Fridriksdottir, Ph.D., Executive VP, R&D Michael (Mike) McClellan, Executive VP & CFO Brendan O'Grady, Executive VP, North America Commercial David M. Stark, Executive VP & CLO Lori Queisser, Senior VP & & Global Compliance Officer
| | Company Description | Teva is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. | |
|
|
|
|
|